Contract Extension

Angle PLC 20 October 2005 For Immediate Release 20 October 2005 ANGLE plc CONTRACT EXTENSION ANGLE plc the venture management and consulting company specialising in the commercialisation of technology is pleased to announce that The Fairfax County Economic Development Authority ('FCEDA') has extended its contract with ANGLE Technology Group US ('ANGLE Technology') through until June 2007. ANGLE Technology, headquartered in Virginia and formed in 1999, is the US technology division of ANGLE plc. The FCEDA promotes Fairfax County, Virginia, as a world-class centre of commerce and trade and the technology hub of the east coast of the United States. The contract extension value is $0.47 million taking the total contract value since commencement in October 2001 to $1.92 million. Under the terms of the contract, ANGLE Technology is to further develop, manage and provide full on-going support to the BioAccelerator of Fairfax County, a business incubation program set-up in 2002 to develop early-stage biotechnology, biomedical and bioinformatics companies. The FCEDA created the BioAccelerator of Fairfax County to serve as a catalyst for the development of the bioscience industry in Northern Virginia. The role of ANGLE Technology ranges from business plan review, sales and marketing advice, and business mentoring, to recruitment activities and assistance with financing for companies in the BioAccelerator. These companies represent converging technologies that include bioscience, nanotechnology, environmental sciences, medical devices and software for biomedical research and healthcare. The ANGLE team also actively supports FCEDA marketing investment in international life science companies. Support for these companies focuses on the establishment of US business operations and the development of targeted US marketing activities. Andrew Newland, Chief Executive of ANGLE said: 'Fairfax County is leading location in the United States for biomedical technology. We are delighted that this important contract has again been extended. In addition to its financial value, our work on the BioAccelerator provides us with a pipeline of opportunities for our expanding ventures business in the Mid-Atlantic region of the US.' For further information, please contact: ANGLE plc Tel: +44 (0)1483 295830 Andrew Newland, Chief Executive Ian Griffiths, Finance Director Buchanan Communications Tel: +44 (0)20 7466 5000 Richard Darby, Suzanne Brocks, James Strong Notes to Editors ANGLE plc - founded in 1994, ANGLE is an international venture management and consulting company focusing on the commercialisation of technology and the development of technology-based industry. ANGLE creates, develops and advises technology businesses on its own behalf and for its clients. ANGLE operates from offices in the UK, the US and the Middle East. ANGLE is listed on AIM (AGL.L); further information can be found at www.angleplc.com This information is provided by RNS The company news service from the London Stock Exchange

Companies

Angle (AGL)
UK 100